53629-64-4 Usage
Uses
Used in Pharmaceutical Industry:
Clofoctol is used as an antibiotic and antifungal agent for the treatment of respiratory tract infections and otitis. Its broad-spectrum activity against various bacteria, including both Gram-positive and Gram-negative types, makes it a valuable asset in combating a wide range of infections. The oxime group present in clofoctol allows it to form covalent bonds with bacterial enzyme targets, effectively inhibiting bacterial growth and leading to the resolution of the infection.
Used in Treatment of Various Infectious Diseases:
Clofoctol is used as a therapeutic agent for the treatment of various infectious diseases, particularly those caused by resistant strains of bacteria. Its broad-spectrum antibacterial activity and ability to form covalent bonds with bacterial enzyme targets make it an effective option for treating a variety of infections. Clofoctol is often administered orally or topically, depending on the specific condition being treated.
Check Digit Verification of cas no
The CAS Registry Mumber 53629-64-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,6,2 and 9 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 53629-64:
(7*5)+(6*3)+(5*6)+(4*2)+(3*9)+(2*6)+(1*4)=134
134 % 10 = 4
So 53629-64-4 is a valid CAS Registry Number.
53629-64-4Relevant academic research and scientific papers
Ferandin, Yoan,Bettayeb, Karima,Kritsanida, Marina,Lozach, Olivier,Polychronopoulos, Panagiotis,Magiatis, Prokopios,Skaltsounis, Alexios-Leandros,Meijer, Laurent
, p. 4638 - 4649 (2006)
Indirubins are kinase inhibitory bis-indoles that can be generated from various plant, mollusk, mammalian, and bacterial sources or chemically synthesized. We here report on the synthesis and biological evaluation of 3′-substituted 7-halogenoindirubins. M
Preparation method and application of isatin derivative-Isatin1908
-
Paragraph 0021; 0022; 0033; 0037; 0041; 0045, (2020/02/14)
The invention relates to the field of drug synthesis. In order to solve the problem that in the prior art, a conventional invention product is insufficient in molecular activity and complex in synthesis route, the invention discloses a preparation method
